ENvue Medical (FEED) Net Margin (2014 - 2026)
ENvue Medical's (FEED) quarterly Net Margin came in at 5089.54% in Q2 2026, down 498833.0% year-over-year from N/an in Q2 2025, and down 46.92% quarter-over-quarter from 3464.17% in Q1 2026.
Analysis
ENvue Medical (FEED) Net Margin (2014 - 2026) Analysis & Trends
ENvue Medical (FEED) has reported Net Margin for 13 consecutive years, with 5089.54% the latest figure, recorded in Q2 2026.
- On a quarterly basis, Net Margin fell 498833.0% year-over-year to 5089.54% in Q2 2026; TTM through Jun 2026 was 2553.89%, a 234864.0% decrease from a year earlier, with the FY2025 full-year figure at 657.07%, down 51223.0% from the prior year.
- Net Margin was 5089.54% for Q2 2026 at ENvue Medical, down from 3464.17% in the prior quarter.
- Over five years, Net Margin peaked at 2018.63% in Q4 2022 and troughed at 5089.54% in Q2 2026.
- A 5-year average of 811.18% and a median of 266.94% in 2022 frame the typical range for Net Margin.
- Across the five-year window, Net Margin surged 435178 bps in 2022 and sank 498833 bps in 2026, its largest moves.
- Over 5 years, Net Margin stood at 2018.63% in 2022, then tumbled by 103 bps to 69.07% in 2023, then sank by 367 bps to 322.3% in 2024, then plunged by 1255 bps to 4366.35% in 2025, then slipped by 17 bps to 5089.54% in 2026.
- The last three Net Margin figures came in at 5089.54% (Q2 2026), 3464.17% (Q1 2026), and 4366.35% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 7.37% |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 28.46% |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 15.17% |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 19.37% |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 16.67% |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 13.87% |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 19.04% |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 13.47% |
| 10 | ENvue Medical | 1.83 Mn | 685,650.21 | -266,000.00 | -5,089.54% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -5,089.54% |
| Mar 31, 2026 | -3,464.17% |
| Dec 31, 2025 | -4,366.35% |
| Sep 30, 2025 | -108.03% |
| Jun 30, 2025 | -101.21% |
| Mar 31, 2025 | -182.63% |
| Dec 31, 2024 | -322.30% |
| Sep 30, 2024 | -265.43% |
| Jun 30, 2024 | -84.21% |
| Mar 31, 2024 | -63.84% |
| Dec 31, 2023 | -69.07% |
| Sep 30, 2023 | -158.73% |
| Jun 30, 2023 | -365.31% |
| Mar 31, 2023 | -309.89% |
| Dec 31, 2022 | 2,018.63% |
| Sep 30, 2022 | -984.54% |
| Jun 30, 2022 | -268.45% |
| Mar 31, 2022 | -416.18% |
| Dec 31, 2021 | -318.32% |
| Sep 30, 2021 | -1,337.47% |